- Home
- Companies
- PharmAI GmbH
- Services
- Focused Screening Services
Focused Screening Services
pharmAI`s innovative solution, which is based on analysing the binding sites, decreases the screening space dramatically. pharmAIs algorithms provide the drug developers with predictions of one or multiple constrained compound space(s) that can easily be passed on to compound library manufacturers (for cherry picking).
Consequently, our DiscoveryEngine can shorten the drug discovery process by short-cutting and optimizing the screening process leading to better results while lowering the costs. Furthermore, at the same time, the diversification of relevant scaffolds are enriched.
Another advantage of using pharmAi`s services is that an off-target analysis and prediction are provided. Usually, both can be challenging in the conventional drug discovery process.